XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 -0.03 (-1.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Other Accumulated Expenses (2020 - 2023)

Updated

XORTX Therapeutics (XRTX) reported Other Accumulated Expenses of $47,361 for the quarter ended Mar 31, 2023, up 41.0% from $33,585 a year earlier but down 59.1% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Other Accumulated Expenses (2020 - 2023) Analysis & Trends

As of Dec 31, 2022, XORTX Therapeutics posted Other Accumulated Expenses of $120,913, down 18.6% from the prior year.

  • Other Accumulated Expenses has a three-year compound annual growth rate of 139.7% (years ended Dec 2019 to Dec 2022).
  • By year, Other Accumulated Expenses came in at $148,487 in the year ended Dec 31, 2021 (+857.4%), $15,510 in the year ended Dec 31, 2020 (+76.7%) and $8,776 in the year ended Dec 31, 2019.
  • Five-year quarterly Other Accumulated Expenses spans a low of $11,498 in the quarter ended Mar 31, 2021 and a high of $115,810 in the quarter ended Dec 31, 2022.
  • Year over year, Other Accumulated Expenses has now increased in each of the last six quarters, with growth averaging 68.6% over the last eight quarters.
  • The high point for year-over-year Other Accumulated Expenses in five years was the quarter ended Mar 31, 2022 (growth of 192.1%); the low point was the quarter ended Sep 30, 2021 (a decline of 15.5%).
  • Per Business Quant data, the three quarters before the quarter ended Mar 31, 2023 came in at $115,810 (quarter ended Dec 31, 2022), $25,123 (quarter ended Sep 30, 2022) and $37,949 (quarter ended Jun 30, 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 XORTX Therapeutics 1.61 Mn -1.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 47,361.00
Dec 31, 2022 115,809.70
Sep 30, 2022 25,123.21
Jun 30, 2022 37,948.75
Mar 31, 2022 33,585.00
Dec 31, 2021 93,485.93
Sep 30, 2021 23,239.65
Jun 30, 2021 36,903.00
Mar 31, 2021 11,498.31
Dec 31, 2020 39,992.70
Sep 30, 2020 27,486.52
Jun 30, 2020 14,063.00
Mar 31, 2020 11,763.00
API Access

XORTX Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY